Multiple Sclerosis Drug Copaxone Gets FDA “Black Box Warning” After Deaths, Allergic Reactions
Potentially deadly allergic reactions from Copaxone use can occur at least a year after starting treatment, the agency warns.
January 23, 2025 By: Martha Garcia
Potentially deadly allergic reactions from Copaxone use can occur at least a year after starting treatment, the agency warns.
A lawsuit filed by six women claim the recalled BioZorb implant was defectively designed, causing pain, infections, swelling and fears of a return of their breast cancer.
A federal judge has ordered plaintiffs and defendants involved in hair relaxer cancer litigation to select 20 cases each, for a total of 40, to undergo case-specific discovery to prepare them to serve as potential bellwether trials.
A federal judge has approved the direct filing of AngioDynamics port catheter lawsuits in the U.S. District Court for the District of Southern California, where the litigation has been centralized for coordinated discovery and pretrial proceedings.
"*" indicates required fields